Mike Curley
About Mike Curley
Mike Curley is an R&D professional specializing in Cell Line Development at Asklepios BioPharmaceutical, Inc. He has an extensive academic background in reproductive biology and biomedical sciences, having earned a PhD from The University of Edinburgh.
Work at Asklepios BioPharmaceutical
Mike Curley currently holds the position of R&D - Cell Line Development at Asklepios BioPharmaceutical, Inc. (AskBio). He has been with the company since 2021, contributing to the development of cell lines for biopharmaceutical applications. His role involves research and development activities aimed at enhancing the efficiency and effectiveness of cell line production, which is critical for the manufacturing of biologics.
Education and Expertise
Mike Curley has a solid educational background in biological sciences. He earned a Doctor of Philosophy (PhD) in Reproductive Biology from The University of Edinburgh, where he studied from 2013 to 2017. Prior to that, he completed a Master of Science by Research (MScR) in Reproductive Sciences at the same institution in 2013. His undergraduate studies culminated in a Bachelor of Science with Honours (BSc hons) in Biological and Biomedical Sciences from Edinburgh Napier University, completed in 2012.
Background
Before joining Asklepios BioPharmaceutical, Mike Curley worked as a Postdoctoral Researcher at The University of Edinburgh from 2017 to 2021. During this four-year period, he engaged in advanced research projects, further developing his expertise in reproductive biology and cell line development. His academic and research experiences have equipped him with a comprehensive understanding of the biological sciences and their applications in the pharmaceutical industry.
Research Experience
Mike Curley's research experience includes a significant tenure as a Postdoctoral Researcher at The University of Edinburgh. His work during this time focused on various aspects of reproductive biology, contributing to the academic community through research initiatives. This experience has laid a strong foundation for his current role in R&D at Asklepios BioPharmaceutical, where he applies his research skills to practical applications in cell line development.